NCT00238225View on ClinicalTrials.gov

Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

June 30, 2006

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DIETARY_SUPPLEMENT

calcitriol

DRUG

dexamethasone

DRUG

ketoconazole

Trial Locations (1)

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT00238225 - Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors | Biotech Hunter | Biotech Hunter